» Authors » Adriana Liptakova

Adriana Liptakova

Explore the profile of Adriana Liptakova including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 19
Citations 79
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Boattini M, Bianco G, Bastos P, Mavromanolaki V, Maraki S, Spiliopoulou A, et al.
Int J Antimicrob Agents . 2025 Mar; :107478. PMID: 40024606
Introduction: Despite being implicated in a wide spectrum of community- and healthcare-acquired infections, anaerobes have not yet been incorporated into systematic surveillance programs in Europe. Methods: We conducted a multicentre...
2.
Straka M, Hubenakova Z, Janosikova L, Bugalova A, Minich A, Wawruch M, et al.
Int J Mol Sci . 2024 Dec; 25(23). PMID: 39684595
The treatment of infections caused by is currently complicated by the increasing number of strains resistant to antimicrobial agents. One promising way to solve this problem is phage therapy. Due...
3.
Jalali Y, Kolosova A, Liptakova A, Kyselovic J, Olearova A, Jalali M, et al.
Pharmaceuticals (Basel) . 2024 Nov; 17(11). PMID: 39598427
Background/objectives: Over the past few decades, extended-spectrum β-lactamase (ESBL)-producing bacteria have become a great concern in healthcare systems worldwide, imposing large burdens by increasing antimicrobial resistance and patient morbidity. Given...
4.
Voronkina I, Liptakova A, Dyachenko V, Derkach S, Sklyar N
Bratisl Lek Listy . 2024 Nov; 125(11):728-733. PMID: 39487844
Background: The goal of our work was to develop a composition for antimicrobial photodynamic inactivation (aPDI) of anaerobic periodontopathogenic pathogens. Methods: The three test groups were as follows: light plus...
5.
Ficik J, Andrezal M, Drahovska H, Bohmer M, Szemes T, Liptakova A, et al.
Antibiotics (Basel) . 2023 Aug; 12(8). PMID: 37627705
The COVID-19 era brought about new medical challenges, which, together with nosocomial bacterial infections, resulted in an enormous burden for the healthcare system. One of the most alarming nosocomial threats...
6.
Koren J, Andrezal M, Ozaee E, Drahovska H, Wawruch M, Liptakova A, et al.
Antibiotics (Basel) . 2023 Jul; 12(7). PMID: 37508305
The expansion of sequence type 131 (ST131) extended-spectrum β-lactamase (ESBL)-producing () represents major worldwide challenges. strains originating from healthcare facilities (labeled No. 1 and No. 2) of the University Hospital...
7.
Jalali Y, Liptakova A, Jalali M, Payer J
Antibiotics (Basel) . 2023 Jul; 12(7). PMID: 37508296
imposes a great burden on medical systems worldwide. Surveillance of trends of antibiotic resistance provides a great deal of information needed for antimicrobial stewardship programmes nationwide. Clinical data from long-term,...
8.
Koren J, Zaborska M, Varga I, Zahumensky J, Liptakova A
Bratisl Lek Listy . 2023 Mar; 124(6):417-420. PMID: 36876375
Objective: Our aim was to determine the effect of immunomodulatory therapy in women with chronic and recurrent vulvovaginal candidiasis (RVVC). Background: We present recent highlights in the research into vaginal...
9.
Koren J, Andrezal M, Drahovska H, Hubenakova Z, Liptakova A, Maliar T
Antibiotics (Basel) . 2022 Nov; 11(11). PMID: 36358193
Carbapenem-resistant (CR) represents an urgent worldwide threat. We focused on CR in selected facilities of the University Hospital Bratislava (UHB) to investigate sequence types (STs), clonal relatedness, and antimicrobial resistance....
10.
Straka M, Hubenakova Z, Lichvarikova A, Janosikova L, Markuskova B, Minich A, et al.
Bratisl Lek Listy . 2022 Aug; 123(10):724-729. PMID: 35913007
Objectives: The aim of this study was to determine the susceptibility of Staphylococcus aureus strains to commercial phage preparations. The strains were isolated from clinical patients as well as from...